News Focus
News Focus
icon url

DewDiligence

06/24/15 8:28 AM

#192870 RE: madrose1 #164397

TTHI—Phase-2/3 trial of ELND005 in agitation/aggression of AD fails primary endpoint:

http://finance.yahoo.com/news/transition-therapeutics-announces-results-clinical-100100129.html